524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Performance
- Low
- ₹46
- High
- ₹51
- 52 Week Low
- ₹7
- 52 Week High
- ₹51
- Open Price₹46
- Previous Close₹49
- Volume754,848
Investment Returns
- Over 1 Month + 24.9%
- Over 3 Month + 84.16%
- Over 6 Month + 249.93%
- Over 1 Year + 640.38%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 187.3
- PEG Ratio
- -10.9
- Market Cap Cr
- 2,240
- P/B Ratio
- Average True Range
- 2.37
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1
- RSI
- 77.98
- MFI
- 83.65
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹51.16
+
2.4
(4.92%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹42.56
- 50 Day
- ₹39.09
- 100 Day
- ₹33.92
- 200 Day
- ₹27.43
Resistance and Support
49.56
- R3 57.65
- R2 54.42
- R1 52.79
- S1 47.93
- S2 44.70
- S3 43.07
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results | |
| 2025-06-04 | Final Dividend | |
| 2025-05-29 | Audited Results |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹51 As on 12 December, 2025 | 22:26
The Market Cap of Shukra Pharmaceuticals is ₹2240.2 Cr As on 12 December, 2025 | 22:26
The P/E ratio of Shukra Pharmaceuticals is 187.3 As on 12 December, 2025 | 22:26
The PB ratio of Shukra Pharmaceuticals is 41.3 As on 12 December, 2025 | 22:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.